D-SPECT衍生心肌血流储备对冠状动脉微血管病的检测及完全血运重建后结局的预后价值:一项双中心试点研究
这项双中心前瞻性研究纳入174例PCI术后造影确认完全血运重建的患者,用动态D-SPECT量化整体和区域心肌血流储备(MFR),以整体或区域MFR<2.0且无>50%心外膜狭窄定义冠状动脉微血管病(CMD)。中位随访12个月,24.1%患者发生MACE;CMD是MACE的独立预测因子(HR=2.46),区域MFR较整体MFR提供增量预后价值。
要点
- PCI完全血运重建后CMD患者MACE发生率显著更高(log-rank χ²=11.375,P=0.001)。
- 多因素调整后CMD仍为MACE独立预测因子(HR=2.46;95%CI 1.27-4.76;P=0.007)。
- 区域MFR较整体MFR提供增量预后价值(NRI=0.524;IDI=0.036)。
核心结论
- 在PCI完全血运重建患者中,D-SPECT衍生CMD与未来MACE风险增加逾2倍相关,独立于传统危险因素和灌注异常。
- 区域MFR较整体MFR提供增量预后价值。
- 上述发现为探索性,需多中心、更长随访并与有创测量对照的研究验证。
研究设计与样本
- 双中心前瞻性研究,纳入174例造影确认PCI术后完全血运重建的患者。
- 用动态D-SPECT在静息和药物负荷下量化整体和区域MFR。
- CMD定义为无>50%心外膜狭窄时整体或区域MFR<2.0。
- 主要终点MACE为全因死亡、心肌梗死、非计划冠状动脉血运重建、卒中、心力衰竭住院和心绞痛再住院的复合终点。
- 采用多变量Cox回归和重分类分析(NRI/IDI)评估预后价值。
主要发现
- 中位随访12个月(IQR 7-21个月),42例(24.1%)发生MACE。
- CMD患者MACE率显著更高(log-rank χ²=11.375,P=0.001)。
- 多因素调整心血管危险因素和异常心肌灌注显像后,CMD仍为MACE独立预测因子(HR=2.46;95%CI 1.27-4.76;P=0.007)。
- 区域MFR较整体MFR提供显著增量预后价值(NRI=0.524,95%CI 0.202-0.821;IDI=0.036,95%CI 0.007-0.067)。
- CMD与MACE的关联在所有预设亚组中一致。
关键数值与推荐
- CMD定义:无>50%心外膜狭窄时整体或区域MFR<2.0。
- 主要终点MACE:全因死亡、心肌梗死、非计划冠状动脉血运重建、卒中、心力衰竭住院和心绞痛再住院的复合终点。
临床怎么用
- 对PCI术后完全血运重建患者,可用动态D-SPECT量化整体和区域MFR以识别CMD并分层MACE风险。
- 区域MFR较整体MFR提供增量预后信息,判读时宜同时关注区域MFR。
- 上述应用属探索性,需多中心更长随访及与有创测量对照验证后再常规推广。
局限性
- 为双中心试点研究,样本量174例,发现属探索性。
- 中位随访仅12个月(IQR 7-21个月),随访时间较短。
- 未与有创测量对照,需多中心更长随访研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This two-center prospective study sought to evaluate whether D-SPECT-derived myocardial flow reserve (MFR) can identify coronary microvascular disease (CMD) and predict major adverse cardiac events (MACE) in patients who had undergone complete revascularization by percutaneous coronary intervention (PCI). METHODS: We enrolled 174 patients with angiographically confirmed complete revascularization post-PCI. Global and regional MFR were quantified using dynamic D-SPECT at rest and during pharmacological stress. CMD was defined as global or territorial MFR < 2.0 in the absence of > 50% epicardial stenosis. The primary endpoint was major adverse cardiac events (MACE), defined as a composite of all-cause death, myocardial infarction, unscheduled coronary revascularization, stroke, heart failure hospitalization, and rehospitalization for angina pectoris. Multivariable Cox regression and reclassification analyses (NRI/IDI) were used to assess prognostic value. RESULTS: Over a median follow-up of 12 months (interquartile range, IQR 7-21 months), 42 patients (24.1%) experienced MACE. Patients with CMD had significantly higher MACE rates (log-rank χ²=11.375, P = 0.001). After multivariate adjustment for cardiovascular risk factors and abnormal myocardial perfusion imaging, CMD remained an independent predictor of MACE (HR = 2.46; 95%CI: 1.27-4.76; P = 0.007). Regional MFR provided significant incremental prognostic value over global MFR (NRI = 0.524, 95%CI: 0.202-0.821; IDI = 0.036, 95%CI 0.007-0.067). The association between CMD and MACE was consistent across all prespecified subgroups. CONCLUSION: In this two-center cohort of patients with complete revascularization after PCI, D-SPECT-derived CMD is associated with a > 2-fold increased risk of future MACE, independent of traditional risk factors and perfusion abnormalities. Regional MFR provides incremental prognostic value beyond global MFR. These findings are exploratory and warrant validation in multi-center studies with longer follow-up and comparisons with invasive measurements.
引用
- Wang R, Bai J, Xie P, et al. Prognostic value of D-SPECT-derived myocardial flow reserve in detecting coronary microvascular disease and predicting outcomes after complete revascularization: a two-center pilot study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42680912. doi:10.1007/s00259-026-08162-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。